Skip to main content


On May 11th, Mr. Rajinder Suri represented DCVMN and its members at the 2023 BIO KOREA International Convention in Seoul, South Korea. DCVMN CEO was invited to give a presentation and participate as a panelist at “Global Vaccine Supply Chain and Innovative R&D Collaboration” session.

In his presentation, Mr. Suri showcases DCVMs’ innovations in R&D and their building of the global vaccine supply chain. He praised the work done by DCVMs during the pandemic and the increasing South-to-South collaborations. Attention was brought to the various vaccine technologies utilized by DCVMN members, such as mRNA, during the fight against COVID-19 and for future pandemic preparedness. Furthermore, he discussed the key vaccine supply chain issues & priorities with a particular focus on traceability, stockpiling, and new packaging and delivery technologies. Mr. Suri presented the successful work done by DCVMN and its members on: primary & secondary vaccine packaging through barcode identification & authentication; distribution and tracking of vaccines through the digitalization of the process; the temperature and security delivery monitoring of the vaccines.

Effective collaboration between stakeholders, use of technology and robust supply chain management strategies are essential to ensure a smooth and steady supply of vaccines everywhere!